We are live on ! Find out more
BTW

Boston Trust Walden Portfolio holdings

AUM $12.2B
1-Year Est. Return 12.45%
This Fund
S&P 500
This Quarter Est. Return
+7.94%
1 Year Est. Return
+12.45%
3 Year Est. Return
+44.66%
5 Year Est. Return
+68.67%
10 Year Est. Return
+295.88%
AUM
$6.82B
AUM Growth
+$400M
Cap. Flow
-$64.1M
Cap. Flow %
-0.94%
Top 10 Hldgs %
17.87%
Holding
394
New
21
Increased
124
Reduced
197
Closed
10

Top Buys

1
BDX icon
Becton Dickinson
BDX
+$14.8M
2
HSIC icon
Henry Schein
HSIC
+$14.3M
3
HON icon
Honeywell
HON
+$14.2M
4
MD icon
Pediatrix Medical
MD
+$13.5M
5
CRL icon
Charles River Laboratories
CRL
+$13.3M

Top Sells

1
BCR
CR Bard Inc.
BCR
+$62.1M
2
CVS icon
CVS Health
CVS
+$18M
3
ACH
Accendra Health
ACH
+$14.8M
4
UI icon
Ubiquiti
UI
+$13.1M
5
EGBN icon
Eagle Bancorp
EGBN
+$11.4M

Sector Composition

1 Financials 19.36%
2 Healthcare 15.63%
3 Technology 15.4%
4 Industrials 13.63%
5 Consumer Discretionary 8.69%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
NTRS icon
26
Northern Trust
NTRS
$33.9B
$62.6M 0.92%
627,112
+23,210
+4% +$2.21M
CB icon
27
Chubb
CB
$136B
$62.3M 0.91%
426,628
-4,593
-1% -$686K
MTD icon
28
Mettler-Toledo International
MTD
$26.4B
$59.6M 0.87%
96,219
-11,136
-10% -$7.12M
OMC icon
29
Omnicom Group
OMC
$23.4B
$57M 0.84%
782,595
-93,555
-11% -$6.71M
DCI icon
30
Donaldson
DCI
$10.5B
$56.2M 0.82%
1,148,633
-13,831
-1% -$659K
UPS icon
31
United Parcel Service
UPS
$100B
$55.8M 0.82%
468,674
-2,880
-0.6% -$338K
PPG icon
32
PPG Industries
PPG
$26.2B
$55M 0.81%
470,950
+31,860
+7% +$3.67M
XRAY icon
33
Dentsply Sirona
XRAY
$2.79B
$54.4M 0.8%
826,074
+10,363
+1% +$659K
AXP icon
34
American Express
AXP
$242B
$53.5M 0.78%
538,660
+225
+0% +$21.4K
BRK.B icon
35
Berkshire Hathaway Class B
BRK.B
$1.06T
$52.8M 0.77%
266,227
+6,835
+3% +$1.3M
WAT icon
36
Waters Corp
WAT
$36.3B
$51.1M 0.75%
264,407
-989
-0.4% -$191K
SBUX icon
37
Starbucks
SBUX
$120B
$49.9M 0.73%
868,183
+21,620
+3% +$1.22M
ES icon
38
Eversource Energy
ES
$28B
$49.2M 0.72%
778,104
+14,473
+2% +$915K
STT icon
39
State Street
STT
$50.4B
$49M 0.72%
502,072
+6,435
+1% +$615K
LECO icon
40
Lincoln Electric
LECO
$13.9B
$46.8M 0.69%
510,638
+115,841
+29% +$10.6M
TROW icon
41
T. Rowe Price
TROW
$25.1B
$44.2M 0.65%
421,080
-8,890
-2% -$867K
CL icon
42
Colgate-Palmolive
CL
$74.4B
$44.1M 0.65%
585,070
-13,690
-2% -$1,000K
ED icon
43
Consolidated Edison
ED
$41.2B
$42.9M 0.63%
504,728
-5,370
-1% -$461K
XOM icon
44
ExxonMobil
XOM
$611B
$42.6M 0.62%
509,508
-8,557
-2% -$708K
OGS icon
45
ONE Gas
OGS
$5B
$42.1M 0.62%
575,244
-5,243
-0.9% -$397K
EMR icon
46
Emerson Electric
EMR
$78B
$42.1M 0.62%
604,123
-16,654
-3% -$1.08M
CINF icon
47
Cincinnati Financial
CINF
$27.9B
$42M 0.62%
560,467
-29,773
-5% -$2.22M
COP icon
48
ConocoPhillips
COP
$139B
$39.6M 0.58%
722,209
+35,501
+5% +$1.83M
MDT icon
49
Medtronic
MDT
$107B
$39.2M 0.57%
485,079
-28,467
-6% -$2.28M
TFC icon
50
Truist Financial
TFC
$65.7B
$38.4M 0.56%
771,800
+158,940
+26% +$7.67M
1
2
3 4 5

Similar funds

GLA
Great Lakes Advisors Chicago, Illinois $12.1B AUM 29.3% 1-Year Est. Return
PIF
Public Investment Fund Al Aqiq District, Riyadh, Saudi Arabia $12B AUM 0.61% 1-Year Est. Return
II
IFM Investors Melbourne, Australia $12B AUM 27.64% 1-Year Est. Return
SMDAM
Sumitomo Mitsui DS Asset Management Tokyo, Japan $12.4B AUM 25.9% 1-Year Est. Return
JIC
Johnson Investment Counsel Cincinnati, Ohio $12.4B AUM 17.21% 1-Year Est. Return
MG
Markel Group Glen Allen, Virginia $11.9B AUM 10.84% 1-Year Est. Return
BS
Banco Santander Madrid, Spain $12.4B AUM 29.42% 1-Year Est. Return
LC
Loews Corp New York $11.9B AUM 8.99% 1-Year Est. Return

Boston Trust Walden's Q4 2017 Portfolio in Review

As of Q4 2017, Boston Trust Walden held 394 positions worth $6.82B, up 6.2% from $6.42B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Boston Trust Walden's Q4 2017 filing shows 21 new, 124 increased, 197 reduced and 10 closed positions. Its largest new stake was Charles River Laboratories: 122,536 shares worth $13.4M. The largest sale was CR Bard Inc., an estimated $62.1M.

By sector, the portfolio is most concentrated in Financials at 19% of assets, down from 19% a quarter earlier, followed by Healthcare and Technology.

  • Boston Trust Walden's largest Q4 2017 buy was Charles River Laboratories: 122,536 shares worth $13.4M.
  • Boston Trust Walden added most to Becton Dickinson in Q4 2017, an estimated $14.8M increase.
  • Boston Trust Walden's biggest Q4 2017 reduction was CVS Health, cutting an estimated $18M.
  • Boston Trust Walden fully exited CR Bard Inc. in Q4 2017, selling an estimated $62.1M.
  • Boston Trust Walden's ten largest holdings make up 18% of its $6.82B portfolio in Q4 2017.
  • Boston Trust Walden opened 21 new positions and closed 10 in Q4 2017.
  • Boston Trust Walden's portfolio value rose 6.2% quarter-over-quarter to $6.82B.

Based on Boston Trust Walden's 13F filing for Q4 2017, filed 29 Jan 2018.